Advertisement
U.S. Markets closed

Akums Drugs and Pharmaceutical (AKUMS.BO)

BSE - BSE Real Time Price. Currency in INR
903.25-10.30 (-1.13%)
At close: 03:29PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 139.87B
Enterprise Value 142.64B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.58
Price/Book (mrq)19.71
Enterprise Value/Revenue 3.55
Enterprise Value/EBITDA 109.21

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31,174.85
52 Week Low 3724.50
50-Day Moving Average 3887.33
200-Day Moving Average 3883.74

Share Statistics

Avg Vol (3 month) 377.36k
Avg Vol (10 day) 311.12k
Shares Outstanding 5153.1M
Implied Shares Outstanding 6N/A
Float 825.58M
% Held by Insiders 182.61%
% Held by Institutions 18.64%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 5.78%
Operating Margin (ttm)8.84%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)42.31B
Revenue Per Share (ttm)295.79
Quarterly Revenue Growth (yoy)5.10%
Gross Profit (ttm)N/A
EBITDA 4.96B
Net Income Avi to Common (ttm)2.44B
Diluted EPS (ttm)0.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.77B
Total Cash Per Share (mrq)18.8
Total Debt (mrq)5.65B
Total Debt/Equity (mrq)78.45
Current Ratio (mrq)N/A
Book Value Per Share (mrq)49.59

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A